C34H39N3O8 Cytidine, 5'-O-[bis (4-methoxyphenyl) phenylmethyl] -2'-O- (2-methox ethyl) -5-methyl- (9CI, ACI)

SILES Canonical O=C1N=C(N)C(=CN1C2OC(COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)C(O)C2OCCOC)C
Isomeric SMILES C (OC [C @ H] 1O[C @ H] ([C @ H] (OCCOC) [C@@H] 1O) N2C (= O) N = C (N) C (C) = C2) (C3 = CC = C (OC) C = C3)
InChi
InChi=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19) -18-40-2)29(38)28(45-32)21-44-34(23-8-6-5-7-9-23,24-10-14-26(4) 1-3)15-11-24)25-12-16-27(42-4)17-13-25/h5-17,20,28-30,32,38H,18-19,21H2,1-4H3,(H2,35,36,39)/t2-35,-36,39)/t28-,0s
InChi Key
LYKTVJJXZQTNPK-PBAMLIMUSA-N
24 Awọn orukọ miiran fun nkan yii
5'-O-[Bis (4-methoxyphenyl) phenylmethyl] -2'-O- (2-methoxyethyl) -5-methylcytidine (ACI); 11: PN: US20030170636 EWE: 17 so RNA; 12: PN: US20030211606 EWE: 18 so R NA; 12: PN: US20030212017 EWE: 19 so R NA; 14: PN: US20040005569 PAG E: 21 beere R NA; 15: PN: US20040005565 OJU: 17- 22 ti o ni ẹtọ RNA; 15: PN: US20040005570 EWE: 19 so R NA; 15: PN: U S20040006030 EWE: 22 so R NA; 15: PN: US20040014048 EWE: 19 so R NA; 16: PN: US20030171313 EWE: 9 so RNA; 16: PN: US20030198965 EWE: 19 so R NA; 16: PN: US20040014047 EWE: 19 so R NA; 16: PN: US20040014049 OJU:

19 beere RNA; 17: PN: US20040014051 EWE: 21 so R NA; 17: PN: US20040014699 EWE: 19 so R NA; 17: PN: W
O03106645 EWE: 69 so R NA; 18: PN: US20040006029 EWE: 22 so R NA; 2'-O-Methoxyethyl-5'-O-dimethoxytril-5- methylcytidine; 58: PN: US20030166592 OJU: 15 beere R NA; 5: PN: WO2005006958 EWE: 61 so R NA; 7: PN: WO20050 07825 EWE: 61 so R NA; 82: PN: US20040171566 EWE: 18 so R NA; 89: PN: US20040005707 EWE: 19 so R NA; 9: PN: WO03084478 EWE: 56 so R NA